Webcast ImageWebcast
Geron at BIO Investor Forum (Live)
10/21/15 at 8:30 a.m. PT
Geron at BIO Investor Forum
Wednesday, October 21, 2015 8:30 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Recent NewsMore >>
10/13/15Geron to Present at the BIO Investor ForumPrinter Friendly Version
09/16/15Geron Announces Initiation of Janssen Phase 2 Clinical Trial of Imetelstat in MyelofibrosisPrinter Friendly Version
09/02/15Dual Publications in the New England Journal of Medicine Highlight Transformative Potential of Imetelstat in Hematologic Myeloid MalignanciesPrinter Friendly Version
Upcoming EventsMore >>
Geron at BIO Investor Forum
Stock Information
GERN (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Change (%) Stock is Down 0.09 (2.99%)
Data as of 10/13/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Contact Information

Anna Krassowska, Ph.D.
Tel: 650-473-7700
E-mail: investor@geron.com or media@geron.com

RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet
Form content here please :)